Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class ASSE: 605033

"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan for 2026

· Issued by Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A

All Shaanxi Meibang Pharmaceutical Group Co., Ltd. Class A news releases